Advertisement

New Aspects on Diagnosis and Transmission of Hepatitis B in Pediatric Patients and Pregnant Women

  • Robert A. de Man
  • Annemiek van der Eijck
  • Irene Veldhuijzen
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 609)

Epidemiologic studies of hepatitis B virus (HBV) show varying levels of endemicity world-wide. The prevalence of chronic HBV in developed nations of Western Europe and North America is about 0.1–0.5% and HBV infection in these societies is usually acquired in adult life through parental or sexual contact. In contrast, in less developed countries as sub-Saharan Africa, Asia and the Far East, HBV is highly endemic and the majority of infections occur in infancy and childhood through horizontal transmission (ie that occurring without apparent parental, sexual or perinatal exposure).

Keywords

Horizontal Transmission Breakthrough Infection Post Exposure Prophylaxis HBeAg Status High Virus Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. del Canho R, Grosheide PM, Mazel JA, Heijtink RA, Hop WC, Gerards LJ, et al. (1997). Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982–1992: protective efficacy and long-term immunogenicity. Vaccine, 15(15):1624–1630.PubMedCrossRefGoogle Scholar
  2. Guettouche T and Hnatyszyn HJ. (2005). Chronic hepatitis B and viral genotype: the clinical significance of determining HBV genotypes. Antivir Ther, 10(5):593–604.PubMedGoogle Scholar
  3. Heermann KH, Gerlich WH, Chudy M, Schaefer S, Thomssen R. (1999). Quantitative detection of hepatitis B virus DNA in two international reference plasma preparations. Eurohep Pathobiology Group. J Clin Microbiol, 37(1):68–73.PubMedGoogle Scholar
  4. Holtby I and McCarron B. (2004). Immunisation of babies of women who screen positive for hepatitis B. Commun Dis Public Health, 7(4):258–259.PubMedGoogle Scholar
  5. Hui AY, Hung LCT, Tse PCH, Leung W-K, Chan PKS, Chan HLY. (2005). Transmission of hepatitis B by detection of virus in saliva and full genome sequencing. J Clin Virology, 33:254–256.Google Scholar
  6. Ip HM, Lelie PN, Wong VC, Kuhns MC, and Reesink HW. (1989). Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA. Lancet, 1(8635):406–410.PubMedCrossRefGoogle Scholar
  7. Kazim SN, Wakil SM, Khan LA, Hasnain SE, Sarin SK. (2002). Vertical transmission of hepatitis B virus despite maternal lamivudine therapy. Lancet, 359(9316):1488–1489.PubMedCrossRefGoogle Scholar
  8. Lau GK, Piratvisuth T, Luo KX, Marcellin P, Thongsawat S, Cooksley G, et al. (2005). Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B. N Engl J Med, 352(26):2682–2695.PubMedCrossRefGoogle Scholar
  9. Lee C, Gong Y, Brok J, Boxall EH, and Gluud C. (2006). Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ, 332(7537):328–336.PubMedCrossRefGoogle Scholar
  10. Seo Y, Yoon S, Truong BX, Kato H, Hamano K, Kato M, et al. (2005). Serum hepatitis B virus DNA levels differentiating inactive carriers from patients with chronic hepatitis B. Eur J Gastroenterol Hepatol, 17(7):753–757.PubMedCrossRefGoogle Scholar
  11. Sloan D, Ramsay M, Prasad L, Gelb D, and Teo CG. (2005). Prevention of perinatal transmission of hepatitis B to babies at high risk: an evaluation. Vaccine, 23(48–49):5500–5508.PubMedCrossRefGoogle Scholar
  12. van Zonneveld M, van Nunen AB, Niesters HG, de Man RA, Schalm SW, and Janssen HL. (2003). Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat, 10(4):294–297.PubMedCrossRefGoogle Scholar
  13. van Zonneveld M, Honkoop P, Hansen BE, Niesters HG, Murad SD, de Man RA, et al. (2004). Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B. Hepatology, 39(3):804–810.PubMedCrossRefGoogle Scholar
  14. Xu WM, Cui YT, Ling-Wang HY, Liang ZQ, Li XM, and Shulin Zhang Q. (2004). Efficacy and safety of lamivudine in late pregnancy for the prevention of mother-child transmission of hepatitis B; a multicentre, randomised, double-blind, placebo-controlled study. 55th Annual meeting of the American Association for the Study of Liver Diseases (AASLD). Boston, MA, USA.Google Scholar

Copyright information

© Springer 2008

Authors and Affiliations

  • Robert A. de Man
    • Annemiek van der Eijck
    • Irene Veldhuijzen

    There are no affiliations available

    Personalised recommendations